ERT Medicines

Concepts

• edinburgh
• pharmaceutical products
• scotland
• supply of ert medicines
• ert medicines
• single supplier framework agreements
• alglucosidase alfa - myozyme
• agalsidase beta - fabrazyme
• imiglucerase - cerezyme
• laronidase - aldurazyme

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Description

Supply of ERT medicines to NHS Scotland: NP92615 (a) Laronidase - Aldurazyme® NP92615 (b) Imiglucerase - Cerezyme® NP92615 (c) Agalsidase Beta - Fabrazyme® NP92615 (d) Alglucosidase Alfa - Myozyme®

Total Quantity or Scope

The Framework Agreements are for the supply of ERT Medicines to NHS Scotland. The Framework Agreements have been awarded as single supplier framework agreements per line to one (1) Framework Participant.

Award Detail

CPV Codes

• 33600000 - Pharmaceutical products

Legal Justification

This VEAT Notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** Total value of the procurement (II.1.7) covers the total fifteen (15) month period, three (3) months which are covered in line with Regulation 72(1)(a) of the Public Contracts (Scotland) Regulations 2015. Total value of the concession/lot (V2.4) covers the twelve (12) month extension period as covered in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015. OJEU notice numbers for each of the individual Awards: NP92619(a)Aldurazyme®- 2019/S 170-415123 NP92619(b)Cerezyme®- 2019/S 170-415129 NP92619(c)Fabrazyme®- 2019/S 170-415117 NP92619(d)Myozyme®- 2019/S 170-415133 (SC Ref:730526)